| 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 176,0 k € | +19.9% | 146,7 k € | +51.5% | 96,9 k € | +14.1% | 84,9 k € | -0.4% | 85,2 k € | +134.6% | 36,3 k € | -46.0% | 67,3 k € | +7.4% | 62,6 k € | +1.0% | 62,0 k € | -0.3% | 62,2 k € | +42.9% | 43,5 k € | +26.3% | 34,5 k € | -1.1% | 34,9 k € | +9.6% | 31,8 k € | -37.8% | 51,1 k € | -0.4% | 51,3 k € | -45.7% | 94,6 k € | |
| EBITDA | 171,4 k € | +18.3% | 144,9 k € | +57.2% | 92,2 k € | +11.6% | 82,6 k € | +0.3% | 82,3 k € | +141.5% | 34,1 k € | -48.3% | 65,9 k € | +6.5% | 61,9 k € | +2.6% | 60,3 k € | +1.0% | 59,7 k € | +48.5% | 40,2 k € | +22.2% | 32,9 k € | -1.2% | 33,3 k € | +11.0% | 30,0 k € | -39.5% | 49,6 k € | -0.5% | 49,9 k € | -46.2% | 92,6 k € | |
| Operating profit | 137,6 k € | +25.2% | 109,9 k € | +98.6% | 55,4 k € | +12.4% | 49,3 k € | -13.2% | 56,7 k € | +607.5% | 8,0 k € | -78.9% | 38,0 k € | +59.9% | 23,8 k € | -5.8% | 25,2 k € | +9.3% | 23,1 k € | +944.9% | 2,2 k € | -57.5% | 5,2 k € | +8.6% | 4,8 k € | +303.0% | -2,4 k € | -110.4% | 22,7 k € | -2.4% | 23,3 k € | -55.4% | 52,1 k € | |
| Profit/loss | 59,8 k € | +92.0% | 31,2 k € | -10.6% | 34,8 k € | +9.9% | 31,7 k € | -7.5% | 34,3 k € | +458.5% | -9,6 k € | -134.9% | 27,4 k € | +106.9% | 13,2 k € | -11.4% | 15,0 k € | +16.9% | 12,8 k € | +632.0% | -2,4 k € | +47.2% | -4,6 k € | +19.5% | -5,7 k € | +57.1% | -13,2 k € | -262.1% | 8,2 k € | -8.2% | 8,9 k € | -75.6% | 36,4 k € | |
| Equity | 264,7 k € | +14.7% | 230,9 k € | -1.3% | 234,0 k € | +17.5% | 199,1 k € | +91.0% | 104,3 k € | +48.9% | 70,0 k € | -12.0% | 79,6 k € | +52.6% | 52,1 k € | +18.8% | 43,9 k € | -0.1% | 43,9 k € | -4.8% | 46,2 k € | -5.0% | 48,6 k € | -8.6% | 53,1 k € | -9.6% | 58,8 k € | -18.4% | 72,0 k € | +12.8% | 63,8 k € | +16.2% | 55,0 k € | |
| Total assets | 402,0 k € | +29.2% | 311,3 k € | +4.5% | 297,8 k € | +4.8% | 284,1 k € | +20.2% | 236,4 k € | +16.8% | 202,4 k € | -8.3% | 220,8 k € | +9.1% | 202,4 k € | -7.5% | 218,9 k € | -7.1% | 235,6 k € | -6.8% | 252,7 k € | +2.7% | 246,0 k € | -7.0% | 264,4 k € | -8.8% | 289,8 k € | -1.1% | 293,0 k € | -4.1% | 305,6 k € | -0.2% | 306,1 k € | |
| Cash | 137,6 k € | -14.6% | 161,0 k € | +34.8% | 119,5 k € | +93.7% | 61,7 k € | +78.4% | 34,6 k € | -32.1% | 51,0 k € | -8.3% | 55,5 k € | +102.9% | 27,4 k € | +69.3% | 16,2 k € | +12.6% | 14,4 k € | +11.6% | 12,9 k € | -24.1% | 17,0 k € | +25.2% | 13,5 k € | +28.3% | 10,6 k € | +149.6% | 4,2 k € | -18.2% | 5,2 k € | -33.0% | 7,7 k € | |
| Debts | 137,3 k € | +70.7% | 80,4 k € | +25.9% | 63,9 k € | -24.8% | 84,9 k € | -35.7% | 132,1 k € | -0.2% | 132,4 k € | -6.3% | 141,3 k € | -6.0% | 150,2 k € | -14.1% | 175,0 k € | -8.7% | 191,6 k € | -7.2% | 206,5 k € | +4.6% | 197,4 k € | -6.6% | 211,3 k € | -8.5% | 231,0 k € | +4.5% | 221,0 k € | -8.6% | 241,8 k € | -3.7% | 251,1 k € | |
Private limited company · Assesse · incorporated on 11/04/2005
Private limited company profitable and well capitalised. Cash position declining (-14.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
SABINE DECKERS ENDOCRINOLOGIE is a Private limited company incorporated in 2005. Its main activity is: Other human health activities. Its registered office is in Assesse.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette